Clinical picture of EPM1-Unverricht-Lundborg disease
- PMID: 18325013
- DOI: 10.1111/j.1528-1167.2008.01546.x
Clinical picture of EPM1-Unverricht-Lundborg disease
Abstract
Unverricht-Lundborg disease (ULD), progressive myoclonic epilepsy type 1 (EPM1, OMIM254800), is an autosomal recessively inherited neurodegenerative disorder characterized by age of onset from 6 to 16 years, stimulus-sensitive myoclonus, and tonic-clonic epileptic seizures. Some years after the onset ataxia, incoordination, intentional tremor, and dysarthria develop. Individuals with EPM1 are mentally alert but show emotional lability, depression, and mild decline in intellectual performance over time. The diagnosis of EPM1 can be confirmed by identifying disease-causing mutations in a cysteine protease inhibitor cystatin B (CSTB) gene. Symptomatic pharmacologic and rehabilitative management, including psychosocial support, are the mainstay of EPM1 patients' care. Valproic acid, the first drug of choice, diminishes myoclonus and the frequency of generalized seizures. Clonazepam and high-dose piracetam are used to treat myoclonus, whereas levetiracetam seems to be effective for both myoclonus and generalized seizures. There are a number of agents that aggravate clinical course of EPM1 such as phenytoin aggravating the associated neurologic symptoms or even accelerating cerebellar degeneration. Sodium channel blockers (carbamazepine, oxcarbazepine) and GABAergic drugs (tiagabine, vigabatrin) as well as gabapentin and pregabalin may aggravate myoclonus and myoclonic seizures. EPM1 patients need lifelong clinical follow-up, including evaluation of the drug-treatment and comprehensive rehabilitation.
Similar articles
-
Progressive Myoclonic Epilepsy Type 1.2004 Jun 24 [updated 2020 Jul 2]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2004 Jun 24 [updated 2020 Jul 2]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301321 Free Books & Documents. Review.
-
Molecular background of EPM1-Unverricht-Lundborg disease.Epilepsia. 2008 Apr;49(4):557-63. doi: 10.1111/j.1528-1167.2007.01422.x. Epub 2007 Nov 19. Epilepsia. 2008. PMID: 18028412 Review.
-
Unverricht-Lundborg progressive myoclonus epilepsy in Oman.Pediatr Neurol. 2008 Apr;38(4):252-5. doi: 10.1016/j.pediatrneurol.2007.11.006. Pediatr Neurol. 2008. PMID: 18358403
-
Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy.Epilepsia. 2006 Oct;47(10):1650-4. doi: 10.1111/j.1528-1167.2006.00638.x. Epilepsia. 2006. PMID: 17054687
-
Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.Eur J Hum Genet. 2007 Feb;15(2):185-93. doi: 10.1038/sj.ejhg.5201723. Epub 2006 Sep 27. Eur J Hum Genet. 2007. PMID: 17003839
Cited by
-
Electroclinical spectrum of the neuronal ceroid lipofuscinoses associated with CLN6 mutations.Neurology. 2015 Jul 28;85(4):316-24. doi: 10.1212/WNL.0000000000001784. Epub 2015 Jun 26. Neurology. 2015. PMID: 26115733 Free PMC article.
-
Transcranial magnetic stimulation as a tool to understand genetic conditions associated with epilepsy.Epilepsia. 2020 Sep;61(9):1818-1839. doi: 10.1111/epi.16634. Epub 2020 Aug 12. Epilepsia. 2020. PMID: 32783192 Free PMC article. Review.
-
The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1.Cells. 2024 Jan 16;13(2):170. doi: 10.3390/cells13020170. Cells. 2024. PMID: 38247861 Free PMC article. Review.
-
Role of cystatin C in neuroprotection and its therapeutic implications.Am J Pathol. 2010 Nov;177(5):2163-5. doi: 10.2353/ajpath.2010.100829. Epub 2010 Sep 23. Am J Pathol. 2010. PMID: 20864683 Free PMC article.
-
A Native Haitian Woman with Unverricht-Lundborg Disease.Case Rep Neurol. 2017 Dec 11;9(3):284-288. doi: 10.1159/000484136. eCollection 2017 Sep-Dec. Case Rep Neurol. 2017. PMID: 29422850 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous